JENBURKT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 ,inter alia, to consider and approve the Standalone unaudited financial results for the quarter and nine months ended on 31st December, 2023.